LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

New approvals — United Kingdom — July 2024

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

23 Jul 2024Tuesday 23 July 2024

open day ◀ ▶ 1 event
MHRA approval GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

19 Jul 2024Friday 19 July 2024

open day ◀ ▶ 1 event
MHRA approval the first generic raltegravir medicines
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 July 2024, approved the first generic raltegravir medicines to treat adult and paediatric HIV patients who weigh at least 4…
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

17 Jul 2024Wednesday 17 July 2024

open day ◀ ▶ 1 event
MHRA approval vibegron
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine vibegron (Obgemsa) to treat the symptoms of overactive bladder (OAB) syndrome in adults.…
What this means, batches, details

Loading…

MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 3 events in this category.